Application Nr Approved Date Route Status External Links
NDA210875 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Kynmobi Is Indicated For The Acute, Intermittent Treatment Of “off” Episodes In Patients With Parkinson's Disease (Pd). Kynmobi Is A Non-Ergoline Dopamine Agonist Indicated For The Acute, Intermittent Treatment Of “off” Episodes In Patients With Parkinson's Disease ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Apomorphine Hydrochloride APOMORPHINE HYDROCHLORIDE ZINC9073

Comments